Appetite-focused weight care
Discuss tirzepatide as part of a personal weight-care plan, with nutrition, activity, and tolerability considered together.
← All treatments
NirvanixInjection
Accelerate & Thrive
Tirzepatide + NAD+Packaging may vary. Compounded by a licensed pharmacy, not Nirvanix.
Weight care, with a clear plan
Accelerate & Thrive
GLP-1 and NAD - Injection
Make hunger easier to manage while bringing weight-loss and everyday energy goals into one plan.
Price pending
- Free shipping
Billing details
Shipping: Free. Final total confirmed before payment.
Shipping is included.
State availability is temporarily unavailable. Please check again before starting.
Loading the selected option…
Online enrollment for this option is being prepared. Existing patients can manage their care.
Frequently asked questions
Does NAD+ make tirzepatide work better?
The studies linked here do not test this combination or show that NAD+ adds to tirzepatide's results.
Are the two ingredients mixed together?
Confirm the exact preparations and their separate instructions during your clinical review. A combined care-plan name is not a mixing instruction.
Can I discuss weight care without NAD+?
Yes. You can compare tirzepatide-only options with this care plan. The assessment should consider each intervention independently and whether a simpler plan fits your needs.
What if I already use tirzepatide or NAD+?
Bring the exact product names, routes, doses, schedules, last use, and any side effects to the assessment. Do not add the second product or change your current treatment without instructions from your prescriber.
How will the combined plan be reviewed?
Ask which goal each ingredient is intended to address, what response and side effects to track, and when to reassess each one. A combined plan does not mean both treatments must continue unchanged.
How do I store and handle my injections?
Use the storage temperature, usable-life date, and handling instructions supplied by your dispensing pharmacy. Concentrations and preparations vary. Ask for clarification before injecting if the label or syringe measurement is unclear.
Safety information & side effects
Tirzepatide has important contraindications and side effects. Review these before starting.
- Do not use with a personal or family history of medullary thyroid cancer, MEN2, or a serious allergy to tirzepatide. Approved tirzepatide carries a boxed warning about thyroid C-cell tumors seen in animals; the risk in humans is unknown.
- Nausea, diarrhea, vomiting, constipation, and abdominal discomfort can occur. Severe or persistent abdominal pain, dehydration, or a serious allergic reaction needs urgent medical assessment.
- Discuss pancreatitis, gallbladder disease, severe stomach-emptying problems, kidney disease, and diabetic eye disease. Insulin and some diabetes medicines can increase low-blood-sugar risk.
- Do not use during pregnancy. Tirzepatide can affect oral contraceptive absorption; discuss additional or non-oral contraception and any planned anesthesia with your clinician. Do not combine with another tirzepatide or GLP-1 medicine unless specifically directed.
- NAD+ adds separate preparation and reaction risks. Review both medicines and their individual instructions; do not mix injections unless explicitly instructed by your pharmacy.
- Compounded medicines are not FDA-approved. Their safety, effectiveness, and quality have not been reviewed by FDA. Discuss approved alternatives and the exact preparation with your clinician.
This is a summary, not a complete prescribing guide. Read the information supplied with your prescription. For a severe allergic reaction or another medical emergency, call 911.
Sources & prescribing informationCompare other formulations & protocols
Different strengths, delivery methods, and combinations need their own clinical review.
Clinician reviewedPersonalized careOnline convenience
A closer look
Understand your options.
Start with what this treatment is, why it may be considered, and what to discuss with your clinician.
NAD+ in the same care plan
Review energy concerns alongside weight goals. Adding NAD+ has not been shown here to improve tirzepatide outcomes.
Coordinated clinical follow-up
Your clinician reviews both ingredients, their instructions, and how the plan fits your needs.
How it works
Two ingredients. Different evidence.
Tirzepatide acts on GIP and GLP-1 receptors. NAD+ participates in cellular metabolism. Evidence for injectable tirzepatide does not establish that adding NAD+ improves weight loss, energy, or tolerability.
Explore the evidenceYour timeline
Care that grows with your needs.
From your first assessment to follow-up, know what comes next. Your clinician sets the pace and the plan.
Complete an assessment covering your weight history, medications, health conditions, and goals.
A clinician assesses eligibility, formulation, alternatives, and any testing needed before a decision.
If prescribed, follow the exact pharmacy label and individual plan. Do not borrow a dosing schedule from another formulation.
Discuss progress and side effects at the follow-up interval set by your clinician. Dose changes depend on your response.
Care milestones are illustrative. Timing, testing, and treatment depend on your clinical review.
Personal care starts with context
Is it right for you?
A weight-care assessment looks beyond a number on the scale.
- Your weight-related health conditions and prior treatment experience.
- Your current medicines, digestive symptoms, and history of pancreatitis or gallbladder problems.
- Pregnancy plans and a personal or family history of medullary thyroid cancer or MEN2.
The evidence behind the conversation
Research & guidance.
Know what was studied, who took part, and how it relates to this option. Study findings are not a prediction of your results.
01SURMOUNT-1 · NEJM, 2022
Average weight reduction was 15.0%, 19.5%, and 20.9% with the three studied doses, compared with 3.1% with placebo.
- Treatment studied / guidance scope
- Subcutaneous tirzepatide 5, 10, or 15 mg weekly, with dose escalation and lifestyle support.
- Who it applies to
- 2,539 adults with obesity, or overweight with a weight-related condition, without diabetes.
- Timeframe
- 72 weeks
- Comparison
- Placebo plus lifestyle support
What this means for this optionThese results do not establish outcomes for low-dose regimens, oral troches, compounded preparations, or combinations with NAD+.
Read the source (opens in a new tab)02NAD+ metabolism pilot · Frontiers, 2019
Researchers measured changes in blood and urine metabolites during and after an NAD+ infusion.
- Treatment studied / guidance scope
- 750 mg NAD+ delivered by a six-hour intravenous infusion.
- Who it applies to
- 11 men: eight received NAD+ and three received saline.
- Timeframe
- A single infusion with eight hours of sampling
- Comparison
- Saline infusion
What this means for this optionEnergy, recovery, cognition, and longevity benefits were not tested. This study does not establish benefits for subcutaneous injections or nasal sprays.
Read the source (opens in a new tab)03FDA guidance · Injectable ingredient quality
FDA reported adverse reactions after compounded NAD+ injections, including reactions consistent with excess endotoxins.
- Treatment studied / guidance scope
- Compounded NAD+ injectable products.
- Who it applies to
- Patients included in adverse-event reports; not an efficacy trial.
- Timeframe
- Safety communication
- Comparison
- No controlled comparator
What this means for this optionReports concern specific product-quality risks and do not measure the frequency of reactions for every preparation.
Read the source (opens in a new tab)04ZEPBOUND · Prescribing information
Approved injectable tirzepatide acts on GIP and GLP-1 receptors and has important contraindications and route-specific instructions.
- Treatment studied / guidance scope
- FDA-approved subcutaneous tirzepatide.
- Who it applies to
- Adults meeting the labeled indications.
- Timeframe
- Current prescribing information
- Comparison
- Not a trial of this offering
What this means for this optionApproval and dosing instructions for the branded injection do not apply automatically to a compounded preparation, oral troche, or combination.
Read the source (opens in a new tab)How we work
Your next chapter
starts with you.
Tell us about yourself
Choose a treatment and complete its assessment when enrollment is available.
Connect with a clinician
Review your options, including any labs or video visit needed for a decision.
Follow your personal plan
If prescribed, begin treatment and stay connected through your patient portal.
Nirvanix Health
Personal care.
Part of your everyday.
The people behind Nirvanix
Your health deserves a thoughtful conversation.
Our founder, Shane Ali, MD, is a board-certified emergency medicine physician. Meet the Nirvanix team and learn about our approach to care.
Meet the teamYour online clinician is assigned according to your treatment and state.
A little more clarity
Your questions, answered.
Comparing costs or getting ready to start? Read our care FAQs.
Have a question about your own care? Sign in to your account.
Does NAD+ make tirzepatide work better?
The studies linked here do not test this combination or show that NAD+ adds to tirzepatide's results.
Are the two ingredients mixed together?
Confirm the exact preparations and their separate instructions during your clinical review. A combined care-plan name is not a mixing instruction.
Can I discuss weight care without NAD+?
Yes. You can compare tirzepatide-only options with this care plan. The assessment should consider each intervention independently and whether a simpler plan fits your needs.
What if I already use tirzepatide or NAD+?
Bring the exact product names, routes, doses, schedules, last use, and any side effects to the assessment. Do not add the second product or change your current treatment without instructions from your prescriber.
How will the combined plan be reviewed?
Ask which goal each ingredient is intended to address, what response and side effects to track, and when to reassess each one. A combined plan does not mean both treatments must continue unchanged.
How do I store and handle my injections?
Use the storage temperature, usable-life date, and handling instructions supplied by your dispensing pharmacy. Concentrations and preparations vary. Ask for clarification before injecting if the label or syringe measurement is unclear.
Your goals. Your next chapter.
Let’s make your care personal.
Start with your history and a conversation about what matters to you.
State availability is temporarily unavailable. Please check again before starting.
Prefer an in-person visit? Explore our Austin clinic.